A5096229576- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Microscopic Colitis
- Esophageal and GI Pathology
- Inflammatory Bowel Disease
- Radiomics and Machine Learning in Medical Imaging
- Systemic Sclerosis and Related Diseases
- Eosinophilic Esophagitis
- Cardiac Imaging and Diagnostics
- Cancer Immunotherapy and Biomarkers
- MRI in cancer diagnosis
Baylor College of Medicine
2024-2025
The management of ultrashort (< 1cm) Barrett's esophagus (BE) remains unclear. We aimed to determine the prevalence BE (USBE) at index diagnosis, identify factors associated with persistent after USBE and risk dysplasia initial in a population United States veterans. This was retrospective cohort study Veterans Affairs hospital Houston, TX consecutive patients new diagnosis from 11/1990 6/2022 follow-up through 4/2023. Using pathology database, we identified any subsequent follow up EGD....
e24084 Background: Immune checkpoint inhibitors (ICI) enhance immune function and may cause gastrointestinal adverse events (GIAEs), such as immune-mediated diarrhea colitis (IMDC). Patients with pre-existing inflammatory bowel disease (IBD) are usually excluded from ICI trials. This study aims to compare GIAE in patients without a history of IBD, elaborating the difference behavior outcome among these two groups. Methods: single-center, retrospective at tertiary care cancer center included...